VOYAGER BIOMEDICAL
Voyager Biomedical, Inc. is committed to improving the lives of dialysis patients through the development of a novel vascular access device known as the ARK. The ARK has been designed to facilitate targeted needle placement and strengthen the vein by serving as a supportive exoskeleton. In addition, the ARK will increase patient comfort, and reduce stress and increase efficiency for caregivers, while benefiting the payer system by decreasing the surgeries necessary to enable long-term vascular access.
VOYAGER BIOMEDICAL
Industry:
Medical Device
Founded:
2016-01-01
Address:
College Station, Texas, United States
Country:
United States
Website Url:
http://www.voyagerbiomedical.com
Total Employee:
1+
Status:
Active
Total Funding:
25 K USD
Technology used in webpage:
Euro Google Maps DreamHost Hosting
Similar Organizations
HAI Solutions Inc.
HAI Solutions focuses on building innovative medical devices in the area of intravenous care and vascular access.
Seno Medical Instruments
Seno Medical is commercialization efforts in opto-acoustic imaging of breast cancer.
SOLUtion Medical
SOLUtion Medical is a developing an autoinjector device aimed at adrenal insufficiency patients.
True Digital Surgery
True Digital Surgery builds a 3D digital surgery visualization platform that improves visualization for a wide range of surgical procedures.
Current Employees Featured
Founder
Investors List
MedTech Innovator
MedTech Innovator investment in Grant - Voyager Biomedical
Texas A&M Innovation
Texas A&M Innovation investment in Grant - Voyager Biomedical
Official Site Inspections
http://www.voyagerbiomedical.com Semrush global rank: 14.82 M Semrush visits lastest month: 37
- Host name: apache2-igloo.iad1-shared-e1-31.dreamhost.com
- IP address: 208.113.190.185
- Location: Brea United States
- Latitude: 33.9339
- Longitude: -117.8854
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 92821
More informations about "Voyager Biomedical"
Voyager Biomedical – Voyager Biomedical
When vascular access is difficult, cannulation can be stressful. The Ark is a state-of-the-art medical device designed to provide a palpable target, allowing easy access to the patient’s …See details»
Voyager Biomedical - Crunchbase Company Profile & Funding
Voyager Biomedical, Inc. is committed to improving the lives of dialysis patients through the development of a novel vascular access device known as the ARK. The ARK has been …See details»
Voyager Biomedical - LinkedIn
Voyager Biomedical, Inc. is committed to improving the lives of dialysis patients through the development of a novel vascular access device known as the Ark. The Ark has been designed to...See details»
Voyager Biomedical Company Profile | Management and
Www.voyagerbiomedical.com Voyager Biomedical Profile and History Voyager Biomedical, Inc. is committed to improving the lives of dialysis patients through the development of a novel …See details»
Voyager Biomedical - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Voyager Biomedical.See details»
Voyager Biomedical Overview | SignalHire Company Profile
Organization Website: voyagerbiomedical.com : Voyager Biomedical industries Medtech: Headquarters Location: 800 Raymond Stotzer Pkwy, College Station, TX, 77845 US 800 …See details»
Voyager Biomedical, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Voyager Biomedical, Inc. of College Station, TX. Get the latest business insights from Dun & Bradstreet.See details»
Voyager Biomedical, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Voyager Biomedical, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Voyager Biomedical - VentureRadar
Website: http://voyagerbiomedical.com. Implant to improve vascular access for dialysis patients. MedTech Innovator Top 100 Companies (2017) Associated sectors: Medtech; Website archive …See details»
Voyager Biomedical - Funding, Financials, Valuation & Investors
Voyager Biomedical is committed to improving the lives of dialysis patients through the development of a novel vascular access device.See details»
Voyager Biomedical | Medical Device
Voyager Biomedical, Inc. is committed to improving the lives of dialysis patients through the development of a novel vascular access device known as the ARK.See details»
Voyager Biomedical - CoBee Company Profile & Funding Rounds
Voyager Biomedical, Inc. is committed to improving the lives of dialysis patients through the development of a novel vascular access device known as the ARK. The ARK has been …See details»
Voyager Biomedical - Overview, News & Similar companies
View Voyager Biomedical (www.voyagerbiomedical.com) location in Texas, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Voyager Biomedical - Products, Competitors, Financials, …
Voyager Biomedical is creating a better solution for vascular access in dialysis patients. You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth …See details»
PATIENT GUIDE - voyagerbiomedical.com
As part of your journey, your doctor has recommended using the Voyager Ark. This guide has been designed to provide information about the investigational Ark device, how it works, what …See details»
Voyager Biomedical - CB Insights
Explore {Voyager Biomedical's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Voyager Biomedical | CipherBio
Explore Voyager Biomedical's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Voyager Therapeutics to Receive $25 Million Payment for
Mar 6, 2023 · Voyager Therapeutics (Nasdaq: VYGR) is a biotechnology company dedicated to breaking through barriers in gene therapy and neurology. The potential of both disciplines has …See details»
Pfizer and Voyager Launch $630 Million Gene Therapy ... - BioSpace
Oct 6, 2021 · Specifically, the deal enables Pfizer to license novel capsids created by Voyager’s RNA-driven TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) …See details»
Voyager Therapeutics to Receive $25 Million Payment for License …
Mar 6, 2023 · With Novartis’ option exercise on two targets, Voyager now receives an additional $25 million option exercise payment and is eligible to receive up to $600 million in associated …See details»